VLP-based bivalent Ebola vaccines and methods of making and using same

COMPOSITIONS AND METHODS USEFUL FOR EBOLA VIRUS INFECTION

VLP-based bivalent ebola vaccines and methods of making and using same

Ebola virus and Marburg virus glycoprotein mucin-like domain replacement expression system used as new vaccine approaches

VIRUS LIKE PARTICLE PRODUCTION IN PLANTS

VIRUS LIKE PARTICLE PRODUCTION IN PLANTS

VLP-BASED MONOVALENT EBOLA VACCINES AND METHODS OF MAKING AND USING SAME

VLP-based bivalent Ebola vaccines and methods of making and using same

FILOVIRUS VECTORS AND PARTICLES PRODUCED THEREFROM

Virus-like particles

Thermostable vaccines based on ether lipids and native viral envelope proteins

Generation of virus-like particles and use as panfilovirus vaccine

Activation of natural killer (NK) cells and methods of use

Filovirus vectors and noninfectious filovirus-based particles

Generation of virus-like particles and use as panfilovirus vaccines

Filovirus vectors and noninfectious filovirus-based particles

VIROSOMES, METHODS OF PREPARATION, AND IMMUNOGENIC COMPOSITIONS

Activation of natural killer (NK) cells and methods of use

Generation of virus-like particles and use as panfilovirus vaccine

Virus-like particles, methods of preparation, and immunogenic compositions

Generation of virus-like particles and use as panfilovirus vaccine